| P50 | author | Peng Yang | Q85820711 |
| | Xiang-Qun Xie | Q89593330 |
| P2093 | author name string | Yun Wang | |
| | Si Chen | |
| | Yifeng Chai | |
| | Zhiwei Feng | |
| | Shifan Ma | |
| | Ziheng Hu | |
| P2860 | cites work | TNF biology, pathogenic mechanisms and emerging therapeutic strategies | Q26776492 |
| | Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist | Q27649040 |
| | Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonists | Q27655087 |
| | Solution of the structure of the TNF-TNFR2 complex | Q27665918 |
| | Structures of the extracellular domain of the type I tumor necrosis factor receptor | Q27733974 |
| | Comparison of multiple Amber force fields and development of improved protein backbone parameters | Q27861040 |
| | Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases | Q28206018 |
| | New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays | Q29615588 |
| | ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins | Q29615866 |
| | 3D structural model of the G‐protein‐coupled cannabinoid CB2 receptor | Q31004521 |
| | GPCR structure-based virtual screening approach for CB2 antagonist search | Q33288322 |
| | A novel small-molecule tumor necrosis factor α inhibitor attenuates inflammation in a hepatitis mouse model | Q33556114 |
| | Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-α/SPD304 Study | Q33635992 |
| | Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs. | Q34222925 |
| | Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat | Q34295016 |
| | Small-molecule inhibitors of the interaction between TNF and TNFR. | Q34519187 |
| | Small-molecule inhibition of TNF-alpha | Q34562550 |
| | Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis | Q34782199 |
| | Discovery of highly potent TNFα inhibitors using virtual screen | Q35216086 |
| | Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations | Q35867767 |
| | Molecular screening of compounds to the predicted Protein-Protein Interaction site of Rb1-E7 with p53- E6 in HPV. | Q36105857 |
| | Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease | Q36727187 |
| | Drug target identification using network analysis: Taking active components in Sini decoction as an example | Q36814771 |
| | Tumor necrosis factor antagonist mechanisms of action: a comprehensive review | Q37043901 |
| | Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents | Q38804396 |
| | Challenging AQP4 druggability for NMO-IgG antibody binding using molecular dynamics and molecular interaction fields | Q39021970 |
| | Structure-based discovery of natural-product-like TNF-α inhibitors | Q41847456 |
| | Japonicone A antagonizes the activity of TNF-α by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1. | Q43426938 |
| | VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. | Q44202604 |
| | Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report | Q45180236 |
| | The in silico identification of small molecules for protein-protein interaction inhibition in AKAP-Lbc-RhoA signaling complex | Q51210441 |
| | Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. | Q51550011 |
| | Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening | Q51660098 |
| | Identification of a ligand for tumor necrosis factor receptor from Chinese herbs by combination of surface plasmon resonance biosensor and UPLC-MS. | Q53080388 |
| | A new gating site in human aquaporin-4: Insights from molecular dynamics simulations | Q56971965 |
| | Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions | Q72344499 |
| | Neutrophilic inflammation in severe persistent asthma | Q73168418 |
| P433 | issue | 5 | |
| P921 | main subject | virtual screening | Q4112105 |
| | TNF | Q18032037 |
| P304 | page(s) | 1101-1111 | |
| P577 | publication date | 2017-04-19 | |
| P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
| P1476 | title | Discovery of Novel Ligands for TNF-α and TNF Receptor-1 through Structure-Based Virtual Screening and Biological Assay | |
| P478 | volume | 57 | |